Q3 2023 13F Holders as of 30 Sep 2023
-
Type / Class
-
Equity / Common Stock
-
Shares outstanding
-
74,822,111
-
Number of holders
-
136
-
Total 13F shares, excl. options
-
62,318,186
-
Shares change
-
-846,547
-
Total reported value, excl. options
-
$395,187,634
-
Value change
-
-$7,310,307
-
Put/Call ratio
-
134%
-
Number of buys
-
70
-
Number of sells
-
58
-
Price
-
$6.34
Institutional Holders of Zymeworks Inc. - Common Stock (ZYME) as of Q3 2023
As of 30 Sep 2023 Zymeworks Inc. - Common Stock (ZYME) had 136 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions held a total of 62,318,186 shares of stock of the company.
Largest 10 holders included EcoR1 Capital, LLC, BVF INC/IL, Redmile Group, LLC, MORGAN STANLEY, BlackRock Inc., Rubric Capital Management LP, CREDIT SUISSE AG/, VANGUARD GROUP INC, FARALLON CAPITAL MANAGEMENT LLC, and BNP PARIBAS ASSET MANAGEMENT Holding S.A..
This table shows 136 institutional shareholders of the security as of 30 Sep 2023.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.